Shares outstanding · 2013–2025
Genmab shares outstanding
64.2M−2.9% · FY2025
Genmab (GMAB) reported 64.2M in shares outstanding for fiscal 2025, −2.9% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | 64.2M | −2.9% | Open → |
| FY20242024-12-31 | 66.2M | +0.2% | Open → |
| FY20232023-12-31 | 66.1M | +0.2% | Open → |
| FY20222022-12-31 | 66.0M | +0.4% | Open → |
| FY20212021-12-31 | 65.7M | +0.3% | Open → |
| FY20202020-12-31 | 65.5M | +0.7% | Open → |
| FY20192019-12-31 | 65.1M | +5.8% | Open → |
| FY20182018-12-31 | 61.5M | +0.5% | Open → |
| FY20172017-12-31 | 61.2M | +1.4% | Open → |
| FY20162016-12-31 | 60.4M | +1.4% | Open → |
| FY20152015-12-31 | 59.5M | +4.5% | Open → |
| FY20142014-12-31 | 57.0M | +10.1% | Open → |
| FY20132013-12-31 | 51.8M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2013–2025 compound annual growth +1.8%
Figures are reported under IFRS, in US dollars.
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Genmab shares outstanding |url=https://companiesranked.com/en/company/genmab/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Genmab shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/genmab/shares-outstandingBibTeX
@misc{companiesranked-en-company-genmab-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Genmab shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/genmab/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001434265-26-000014 · February 17, 2026
{{cite web |title=Genmab shares outstanding — 20-F (0001434265-26-000014) |url=https://www.sec.gov/Archives/edgar/data/1434265/000143426526000014/gmab-20251231_d2.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.